Shares of GemVax Technology Co., Ltd. (KOSDAQ:A041590)rose on news it is acquiring a Sweden-based biotech company. Earlier, GemVax said it was in discussions to acquire a Swedish biotech company which has proprietary rights in regenerative medicine and it will sign a contract on April 16, 2015. The company's stock price gained 5.44%.